JHL Biotech is a renowned biopharmaceutical brand that specializes in the development of biosimilars and offers contract development and manufacturing services to distinguished clients and partners. With a strong emphasis on quality and innovative, cost-effective manufacturing infrastructure, JHL Biotech is actively developing a diverse pipeline of proprietary biosimilars through experienced process optimization. Additionally, JHL Biotech collaborates and licenses innovative biologics for co-development, aiming to address global unmet medical needs and provide long-term benefits.

As a leading player in biologics manufacturing, JHL Biotech stands out for its commitment to innovation. Established in 2012, JHL Biotech is known for its breakthrough engineering and process technologies, delivering high-quality and affordable biosimilar medicines to patients worldwide. The company has an impressive track record, having submitted IND/CTA's to over 20+ countries/regions and passing rigorous regulatory audits/inspections from entities like the Taiwan FDA and EU Qualified Person.

JHL Biotech's vision is to increase the availability of biotechnology medicines globally, making them accessible and affordable for all in need. Their logo reflects their pioneering spirit, depicting green hills, golden fields, and a dazzling sun, symbolizing their mission to build a better and healthier world through the wonders of biotechnology. Safeguarding global healthcare lies at the heart of JHL Biotech's operations